$835 Million American “Pot Stock” Buyout

The Marijuana Buyout Boom is alive and well . . .

Yesterday, we got news of a $835 million merger between two U.S. pot stocks.

It’s the latest deal that’s fueling America’s No. 1 growth sector.

Plus, new privately held cannabis companies are going public in IPOs.

Go here for your “PRE-IPO” prospectus.

iAnthus Capital (OTC: ITHUF) announced plans to merge with MPX Bioceutical (OTC: MPXEF) in a $835 million deal.

MPX shareholders will be issued common stock in ITHUF – valuing their shares at $0.98 (or $1.28 per Canadian-listed share).
That’s a 30.6% premium to the closing price of MPXEF on Oct. 17.

Shares jumped immediately on the news – as you’ll see in this stock chart.

POT STOCK BUYOUT

The deal helps iAnthus double its size. Plus, it expands the business into California, Nevada, Maryland and Arizona.

The combined company will have licenses in 10 states. It will operate 56 retail locations and 14 cultivation and processing facilities.

“The nascent U.S. cannabis market is still in a land-grab phase, and we feel that our footprint when combined with iAnthus, provides our investors with the strongest possible exposure to this explosive marketplace.”

Here’s what the company’s combined business looks like:

For the last six months, I’ve been predicting more M&A activity. Plus, we’re starting to see tons of new companies going public through IPOs and reverse mergers.

It’s a “green gold rush” – and early investors are getting rich.

Frankly, that’s why I was so excited when I heard about this $0.55 Canadian cannabis PRE-IPO.

The company is a 100% government-approved, licensed producer. Plus, it is rolling out its own cannabis brand and retail stores across Canada.

It’s one of those true ground-floor situations.

Right now, a small group of investors have a chance to grab PRE-IPO shares.

That’s right. You could pick up shares for just $0.55 – just 60 days before the company goes public.

Click here now for urgent details.

Yours in Profits,

Ian Wyatt

Published by Wyatt Investment Research at